15. Fibrilación auricular: de paroxística a persistente

Elena Sufrate Sorzano

Elena Sufrate Sorzano Cardiología. Hospital San Pedro, Logroño.

Palabras clave: Fibrilación auricular, Crioablación

Abstract

El tratamiento inicial de la fibrilación auricular (FA) paroxística con crioablación se asocia a menor tasa de FA persistente y de otras taquiarritmias supraventriculares comparado con los fármacos antiarrítmicos.

Initial treatment of paroxismal atrial fibrillation with catheter cryoballoon ablation was associated with a lower incidence of persistent atrial fibrillation or recurrent atrial tachyarrhythmia than initial use of antiarrhythmic drugs.

Citas

Vol. 55; 725-731. De Vos CB, Pisters R, Nieuwlaat R, et al. Progression from paroxismal to persistent atrial fibrillation clinical correlates and prognosis. J Am coll Cardiol 2010. Doi:https:// 10.1016/j.jacc.2009.11.040

Vol. 347; 1825-1833. Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2022. Doi:https:// 10.1056/NEJMoa021328.

Vol. 383; 1305-1316. Kirchhof P, Camm AJ, Goette A, et al. Ealy rhytm-control therapy in patients with atrial fibrillation. N Engl J Med 2020. Doi:https:// 10.1056/NEJMoa2019422

Vol. 384;305-315.Andrade JG, Wells GA, Deyell MW, et al. Cryoablation or drug therapy for initial treatment of atrial fibrillation. N Engl J Med 2021. Doi:https:// 10.1056/NEJMoa2029980

Vol.42; 373-498.Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guildelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Associatrion for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 2021. Doi:https:// 10.1093/eurheartj/ehaa612.